STABLE ISOTOPE METHOD FOR STUDYING TRANSDERMAL DRUG ABSORPTION - THE NICOTINE PATCH

被引:70
作者
BENOWITZ, NL
CHAN, K
DENARO, CP
JACOB, P
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
[2] CIBA GEIGY CORP,ARDSLEY,NY 10502
[3] UNIV CALIF SAN FRANCISCO,LANGLEY PORTER PSYCHIAT INST,SAN FRANCISCO,CA 94143
关键词
D O I
10.1038/clpt.1991.138
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A stable isotope-labeled drug method was used to determine the absolute bioavailability and absorption kinetics of a transdermal nicotine-delivery system (TTS). TTSs are being developed as an adjunct to smoking-cessation therapy. Deuterium-labeled nicotine was infused for 24 hours simultaneously to TTS application in cigarette-abstinent smokers. In 11 subjects with good patch adhesion, an average systemic dose of 19 mg nicotine was delivered, with average absolute bioavailability of 82%. The rate of nicotine absorption was maximal between 6 and 12 hours after TTS application and declined thereafter, plateauing between 16 and 24 hours at 62% of the maximal rate. Ten percent of nicotine was absorbed after the TTS was removed, demonstrating a reservoir for nicotine in the skin. Our study demonstrates the applicability of stable isotope methods in understanding the clinical pharmacology of transdermal drugs.
引用
收藏
页码:286 / 293
页数:8
相关论文
共 20 条
  • [1] ABELIN T, 1989, LANCET, V1, P7
  • [2] BENOWITZ NL, 1982, J PHARMACOL EXP THER, V221, P368
  • [3] PROLONGED ABSORPTION WITH DEVELOPMENT OF TOLERANCE TO TOXIC EFFECTS AFTER CUTANEOUS EXPOSURE TO NICOTINE
    BENOWITZ, NL
    LAKE, T
    KELLER, KH
    LEE, BL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (01) : 119 - 120
  • [4] NICOTINE AND CARBON-MONOXIDE INTAKE FROM HIGH-YIELD AND LOW-YIELD CIGARETTES
    BENOWITZ, NL
    JACOB, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (02) : 265 - 270
  • [5] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS
    BOXENBAU.HG
    RIEGELMA.S
    ELASHOFF, RM
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02): : 123 - 148
  • [6] BOXENBAUM HG, 1968, J PHARMACOKINET BIOP, V3, P257
  • [7] DUBOIS JP, 1989, METHOD FIND EXP CLIN, V11, P187
  • [8] GIBALDI M, 1982, PHARMACOKINETICS, P27
  • [9] SYNTHESIS OF OPTICALLY PURE DEUTERIUM-LABELLED NICOTINE, NORNICOTINE AND COTININE
    JACOB, P
    BENOWITZ, NL
    SHULGIN, AT
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1988, 25 (10) : 1117 - 1128
  • [10] SELECTED ION MONITORING METHOD FOR DETERMINATION OF NICOTINE, COTININE AND DEUTERIUM-LABELED ANALOGS - ABSENCE OF AN ISOTOPE EFFECT IN THE CLEARANCE OF (S)-NICOTINE-3',3'-D2 IN HUMANS
    JACOB, P
    YU, L
    WILSON, M
    BENOWITZ, NL
    [J]. BIOLOGICAL MASS SPECTROMETRY, 1991, 20 (05) : 247 - 252